BioGaia Gastrus is a new, effective and safe probiotic supplement that could improve Helicobacter pylori therapy. BioGaia Gastrus does not replace standard treatment. Clinical studies have shown reduction of inflammation and other symptoms of the infection, as well as reduction of common side effects of the antibiotic treatment. Further, data suggests it may contribute to increased eradication rates.
BioGaia Gastrus could be used as an adjunct to triple or sequential antibiotic therapy for Helicobacter pylori infected patients diagnosed as “high risk”, for dyspeptic patients and for asymptomatic patients.
BioGaia Gastrus is a combination of the well-researched probiotic strain Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri Protectis) and the anti-inflammatory strain Lactobacillus reuteri ATCC PTA 6475. It contains 200 million cfu of live bacteria. The mandarin/mint flavoured tablet can be chewed, swallowed or allowed to melt in the mouth.